2008
DOI: 10.2147/cia.s1044
|View full text |Cite
|
Sign up to set email alerts
|

Carvedilol in the treatment of elderly patients with chronic heart failure

Abstract: Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain undertreated. The aim of the present article is to review the potential mechanisms of the benefi ts of adrenergic blockade in CHF and the clinical data available from the large randomized studies, focusing particularly on older patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 169 publications
(167 reference statements)
0
1
0
Order By: Relevance
“…Total variability as expressed by SD-IBI is lower in CHF, although not statistically significant. HF as short term variability index is higher in CHF, but this may well be due to the β-blockade (Goldsmith et al, 1997; Witte and Clark, 2008). As a consequence LF/HF is significantly lower in CHF as well.…”
Section: Resultsmentioning
confidence: 99%
“…Total variability as expressed by SD-IBI is lower in CHF, although not statistically significant. HF as short term variability index is higher in CHF, but this may well be due to the β-blockade (Goldsmith et al, 1997; Witte and Clark, 2008). As a consequence LF/HF is significantly lower in CHF as well.…”
Section: Resultsmentioning
confidence: 99%